Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Go back to Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results| (NASDAQ: PRAX) | Delayed: 298.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $298.95 | 52 Week High | $ | |||
| Open | $298.95 | 52 Week Low | $ | |||
| Day High | $298.95 | P/E | N/A | |||
| Day Low | $298.95 | EPS | $ | |||
| Volume | 34 | |||||

